STAT3 expression in gastric cancer indicates a poor prognosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 4, 2009, Pages 646-651

  Kim, Dae Young ^a   Cha, Sung Tae ^a   Ahn, Dae Ho ^a   Kang, Hae Yoon ^a   Kwon, Chang Il ^a   Ko, Kwang Hyun ^a   Hwang, Seong Gyu ^a   Park, Pil Won ^a   Rim, Kyu Sung ^a   Hong, Sung Pyo ^a  

^a CHA University   (South Korea)

Author keywords

Gastric cancer; Immunohistochemistry; Prognosis; Signal transducers and activators of transcription (STAT); STAT3; STAT5

Indexed keywords

MOLECULAR MARKER; PROTEIN ANTIBODY; STAT3 PROTEIN; STAT5 PROTEIN;

ADULT; ARTICLE; ATROPHIC GASTRITIS; CANCER SURVIVAL; DISEASE SEVERITY; FEMALE; GASTRECTOMY; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH ADENOCARCINOMA; SURVIVAL RATE; TISSUE CULTURE; TUMOR VOLUME;

EID: 63849197587     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05671.x     Document Type: Article

References (28)

1. Gunderson LL, Donobue JH, Burch PA. Stomach. In : Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE, eds. Clinical Oncology, 2nd edn. New York : Churchill-Livingston, 2001 1545 85.
2. Pisani P, Parkin DM, Bray F, Ferlay J. Erratum. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 1999 83 : 870 3.
3. Price P, Sikore K. Stomach. In : Treatment of Cancer, 4th edn. London : Arnold Press, 2002 583 99.
4. Joong-min P, Young-Jae M. Prognostic factors for advanced gastric cancer: stage stratified analysis of patients who underwent curative resection. Cancer Res. Treat. 2006 38 : 13 18.
5. Kikuchi S, Katada N, Sakuramoto S et al. Survival after surgical treatment of early gastric cancer: surgical techniques and long-term survival. Langenbecks Arch. Surg. 2004 289 : 69 74.
6. Kandi M, Konda Y, Nakajima T et al. Differentiation-inducing factor-1 (DIF-1) inhibits STAT3 activity involved in gastric cancer cell proliferation via MEK-ERK-dependent pathway. Oncogene 2003 22 : 548 54.
7. Faille-Kuyber EH, Kater L, Kooiker CJ, Dorhout Mees EJ. IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch-Schonlein syndrome. Lancet 1973 1 : 892 3.
8. Darnell JE Jr. STATs and gene regulation. Science 1997 277 : 1630 5.
9. Zhong Z, Wen Z, Darnell JE Jr. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc. Natl Acad. Sci. USA 1994 91 : 4806 10.
10. Ni Z, Lou W, Lee SO et al. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J. Urol. 2002 167 : 1859 62.
11. Scholz A, Heinze S, Detjen KM et al. Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. Gastroenterology 2003 125 : 891 905.
12. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000 19 : 2474 88.
13. Huang M, Page C, Reynolds RK, Lin J. Constitutive activation of STAT 3 oncogene product in human ovarian carcinoma cells. Gynecol. Oncol. 2000 79 : 67 73.
14. Song JI, Grandis JR. STAT signaling head and neck cancer. Oncogene 2000 19 : 2489 95.
15. Choi JH, Ahn MJ, Park CK et al. Phospho-Stat3 expression and correlation with VEGF, p53, and Bcl-2 in gastric carcinoma using tissue microarray. APMIS 2006 114 : 619 25.
16. Fenoglio-Preiser C, Munoz N, Carneiro F et al. Gastric carcinoma. In : Hamilton SR, Aaltonen LA, eds. Pathology and genetics of tumours of the digestive system. World Health Organization Classification of Tumours. Lyon : IARCPress. 2000 39 52.
17. Sobin LH, Wittekind CH. UICC TNM Classification of Malignant Tumors, 5th edn. New York : Wiley-Liss, 1997.
18. Gong W, Wang L, Yao JC et al. Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin. Cancer Res. 2005 11 : 1386 93.
19. Calo V, Migliavacca M, Bazan V et al. STAT proteins from normal control of cellular events to tumorigenesis. J. Cell Physiol. 2003 197 : 157 68.
20. Yu H, Jove R. The STATs of cancer-new molecular targets come of age. Nat. Rev. Cancer 2004 4 : 97 105.
21. Bromberg JF. Stat proteins and oncogenesis (review). J. Clin. Invest. 2002 109 : 1139 42.
22. Shizuo A. Functional roles of STAT family proteins: lessons from Knockout Mice. Stem Cells 1999 17 : 138 46.
23. Lin MT, Lin BR, Chang CC et al. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway. Int. J. Cancer 2007 120 : 2600 8.
24. Kanda N, Seno H, Konda Y et al. STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 2004 23 : 4921 9.
25. Seung Young O, Tae Hyoung K, Chul Myung S, Young Sun K. The clinical significance of STAT3 and STAT5 activation in renal cell carcinoma. Korean J. Urol. 2004 45 : 403 9.
26. Schwaller J, Parganas E, Wang D et al. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. Mol. Cell 2000 6 : 693 704.
27. Kato Y, Iwama A, Tadokoro Y et al. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J. Exp. Med. 2005 202 : 169 79.
28. Xie TX, Wei D, Liu M et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004 23 : 3550 60.